FDA approves Biogen and Alkermes’ multiple sclerosis drug Reuters Oct 31, 2019 The approval is good news for Biogen as its top-selling drug Tecfidera, also a multiple sclerosis treatment, is facing patent…
Biogen and Eisai revive plans for Alzheimer’s drug, surprising market Reuters Oct 23, 2019 The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…
Biogen scraps two late-stage trials for Alzheimer’s treatment EP News Bureau Sep 17, 2019 The decision was based on the results of a review conducted by a data safety monitoring board, which recommended discontinuing the…
